Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|August 14, 1999
Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assaysA A Geldof, S C Mastbergen, R E Henrar, et al.
Anti-Cancer Drugs|January 12, 2000
Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administrationB Nuijen, M Bouma, R E Henrar, et al.
Journal of Pharmaceutical Sciences|November 1, 1996
Systematic study on the chemical stability of the prodrug antitumor agent carzelesin (U-80,244)J D Vries, W G Doppenberg, R E Henrar, et al.
British Journal of Cancer|July 1, 1995
CRC/EORTC/NCI Joint Formulation Working Party: experiences in the formulation of investigational cytotoxic drugsJ H Beijnen, K P Flora, G W Halbert, et al.
PDA Journal of Pharmaceutical Science and Technology|November 1, 1995
The influence of formulation excipients on the stability of the novel antitumor agent carzelesin (U-80,244)J D Jonkman-De Vries, H Rosing, R E Henrar, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 29, 1999
Bioanalysis of thiocoraline, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography and fluorescence detectionR W Sparidans, R E Henrar, J M Jimeno, et al.
International Journal of Pharmaceutics|February 29, 2000
In vitro biocompatibility studies with the experimental anticancer agent BIBX1382BSB Nuijen, M Bouma, R E Henrar, et al.
Investigational New Drugs|January 1, 1996
Purity determinations in the bulk drug of the novel indoloquinone antitumor agent EO9J D Jonkman-de Vries, J J Kettenes-van den Bosch, R E Henrar, et al.
Journal of Chromatography|January 14, 1994
Fully automated high-performance liquid chromatographic method for the determination of carzelesin (U-80,244) and metabolites (U-76,073 and U-76,074) in human plasmaO van Tellingen, E M Pels, R E Henrar, et al.
Cancer Research|June 11, 1998
Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humansO van Tellingen, W J Nooijen, L J Schaaf, et al.
Pageof 3